Potassium Chloride Capsule, Extended Release
Product Images NDC 68382-853

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 68382-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (9ecc5efe 412a 499a 8a77 F9a07bca8e10 01)

B B Potassium Chloride Extended-Release Capsules USP is a medication used to release potassium chloride slowly over a period of 8 to 10 hours for the treatment of potassium deficiency. The usual dosage and prescribing information can be found in the package insert. The medication should be stored at controlled room temperature and kept away from children. This medication is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. in packages of 100 capsules.*

FDA Label Image

Figure2 (9ecc5efe 412a 499a 8a77 F9a07bca8e10 02)

Potassium Chloride Extended-Release is a medication that comes in capsules with a dosage of 10mEq containing Potassium Chloride that releases the active ingredient over an 8 to 10 hour period. It is recommended to refer to the package insert for complete prescribing information. The drug should be stored at 20° to 25°C (68° to 77°F) and dispensed in a tight container as defined in the USP. The manufacturer is Cadila Healthcare Lid, located in Ahmedabad, India, and it is distributed by Zydus Pharmaceuticals USA Inc. The product is intended for prescription-only use, and it is essential to keep all drugs out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.